Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruidong Hao

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cellular Oncology (Dordrecht, Netherlands)|June 19, 2025
Synthetic NKG2D receptor (SNR) armored CAR-T cells overcome antigen heterogeneity of solid tumorMinmin Sun, Linke Bian, Hongye Wang, et al.
Hepatology (Baltimore, Md.)|April 24, 2016
Hepatitis B e antigen and its precursors promote the progress of hepatocellular carcinoma by interacting with NUMB and decreasing p53 activityDan Liu, Lei Cui, Yuan Wang, et al.
Frontiers in Microbiology|April 19, 2021
Antiviral Activity of Interferon Alpha-Inducible Protein 27 Against Hepatitis B Virus Gene Expression and ReplicationHafiz Ullah, Muhammad Sajid, Kun Yan, et al.
Molecular Cancer Therapeutics|November 10, 2025
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicitySicheng Du, Ying Zhang, Ruidong Hao, et al.
Science Translational Medicine|January 22, 2025
Triple knockdown of <i>CD11a</i>, <i>CD49d</i>, and <i>PSGL1</i> in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in miceHongye Wang, Zhaorong Wu, Dan Cui, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cellular Oncology (Dordrecht, Netherlands)|June 19, 2025
Synthetic NKG2D receptor (SNR) armored CAR-T cells overcome antigen heterogeneity of solid tumorMinmin Sun, Linke Bian, Hongye Wang, et al.
Hepatology (Baltimore, Md.)|April 24, 2016
Hepatitis B e antigen and its precursors promote the progress of hepatocellular carcinoma by interacting with NUMB and decreasing p53 activityDan Liu, Lei Cui, Yuan Wang, et al.
Frontiers in Microbiology|April 19, 2021
Antiviral Activity of Interferon Alpha-Inducible Protein 27 Against Hepatitis B Virus Gene Expression and ReplicationHafiz Ullah, Muhammad Sajid, Kun Yan, et al.
Molecular Cancer Therapeutics|November 10, 2025
Preclinical development and a case report of a nanobody-based CLDN18.2 CAR-T IMC002 with reduced on-target off-tumor toxicitySicheng Du, Ying Zhang, Ruidong Hao, et al.
Science Translational Medicine|January 22, 2025
Triple knockdown of <i>CD11a</i>, <i>CD49d</i>, and <i>PSGL1</i> in T cells reduces CAR-T cell toxicity but preserves activity against solid tumors in miceHongye Wang, Zhaorong Wu, Dan Cui, et al.
Pageof 2